Company intelligence / Profile preview

Servatus Biopharmaceuticals

Coolum Beach, Queensland, Australiaservatus.com.au ↗
Ownership
Private
Employees
~35
Development stage
Phase 1
01

Overview

Servatus has achieved key clinical milestones indicating potential to change treatment paradigms for severe autoimmune diseases. The company has reported positive results in early clinical studies for insomnia and IBS-C. Its LBP program includes a Phase I trial for H. pylori infection and Phase II trials in autoimmune/inflammatory conditions. The company also produces OTC microbiome-based products targeting skin health and GI symptoms.

Therapeutic areas
GastroenterologyPsychiatryImmunologyInfectious Diseases
Modalities
Live biotherapeutic products (LBPs)Engineered/modified proteins
Industry
Biotech
02

Drug pipeline

10 assets

SVT-1A4710

Preclinical

9 more assets in the full pipeline.

Request access →
03

Partnerships

Partnered with a multinational pharmaceutical organization to fund manufacturing expansionJoint venture with Australian Biotherapeutics on manufacturing technology acquisition

Beyond the preview

Go deeper on Servatus Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Servatus Biopharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call